Living Cell Technologies (LCT)

0.006
-0.001(-14.29%)
  • Volume:
    3,520,862
  • Bid/Ask:
    0.006/0.007
  • Day's Range:
    0.006 - 0.007

LCT Overview

Prev. Close
0.007
Day's Range
0.006-0.007
Revenue
270K
Open
0.006
52 wk Range
0.006-0.024
EPS
0
Volume
3,520,862
Market Cap
5.9M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,831,627
P/E Ratio
-
Beta
1.48
1-Year Change
-58.14%
Shares Outstanding
983,205,686
Next Earnings Date
-
What is your sentiment on Living Cell Technologies?
or
Market is currently closed. Voting is open during market hours.

Living Cell Technologies Company Profile

Employees
0
Market
Australia

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson’s disease. The company was founded in 1987 and is based in Melbourne, Australia.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralNeutralStrong SellStrong Sell
Technical IndicatorsSellSellStrong SellStrong SellStrong Sell
SummaryNeutralNeutralSellStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.